Cancer Family
Childhood Neoplasm
CI-CAN-00000009Explore in graph →
PediatricNon-malignant312 active trials1 approved drugs68 evidence items
- NCIt
- C6283
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000009Explore in graph →
Clinical trials
1,503 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07052994 | A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 23, 2026 | clinicaltrials |
| NCT05454163 | Post-radiotherapy Rhinosinusitis in Children(PRRSC) | withdrawn | — | 0 | University Hospital, LilleOTHER | 0 | May 22, 2026 |
| clinicaltrials |
| NCT03554707 | SGT-53 in Children With Recurrent or Progressive CNS Malignancies | withdrawn | Early Phase 1 | 0 | SynerGene Therapeutics, Inc.INDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT05132673 | Cardiac Autonomic Dysfunction in Childhood Cancer Survivors | withdrawn | — | 0 | St. Jude Children's Research HospitalOTHER | 0 | Apr 24, 2026 | clinicaltrials |
| NCT07222358 | Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery | withdrawn | — | 0 | St. Jude Children's Research HospitalOTHER | 0 | Apr 6, 2026 | clinicaltrials |
| NCT04036045 | Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity | withdrawn | — | 0 | Connecticut Children's Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05000905 | Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training | withdrawn | N/A | 0 | University of California, San FranciscoOTHER | 0 | Aug 6, 2025 | clinicaltrials |
| NCT06013904 | Difficult PIV Placement in the Pediatric ED | withdrawn | N/A | 0 | University of Texas at AustinOTHER | 0 | Jul 4, 2025 | clinicaltrials |
| NCT06023368 | Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray | withdrawn | Phase 4 | 0 | Marianne HuttiOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT04523623 | Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Oct 26, 2024 | clinicaltrials |
| NCT04996745 | Taking POSNA's OrthoKids to the People | withdrawn | N/A | 0 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT05112458 | Cope 360 App for Caregivers of Children With Cancer | withdrawn | N/A | 0 | Indiana UniversityOTHER | 0 | Aug 15, 2024 | clinicaltrials |
| NCT05622591 | ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML(Pediatric AML) | withdrawn | Phase 1 | 0 | Elucida OncologyINDUSTRY | 0 | Aug 7, 2024 | clinicaltrials |
| NCT06335745 | PediCARE Health Equity Intervention in High-Risk Neuroblastoma | withdrawn | N/A | 0 | Dana-Farber Cancer InstituteOTHER | 0 | Aug 5, 2024 | clinicaltrials |
| NCT03955068 | Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children | withdrawn | N/A | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT04019470 | Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors | withdrawn | — | 0 | Capital Medical UniversityOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03179449 | In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI | withdrawn | Early Phase 1 | 0 | Michael IvOTHER | 0 | Apr 14, 2023 | clinicaltrials |
| NCT04311866 | Femoral Pediatric Fractures. Walking Spica Cast vs Synthetic Pants | withdrawn | N/A | 0 | Universidad Autonoma de Nuevo LeonOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT04719416 | Relaxation Therapy in Pediatric Oncology | withdrawn | N/A | 0 | Geisinger ClinicOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT04807478 | Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC) | withdrawn | — | 0 | Fresenius KabiINDUSTRY | 0 | Aug 4, 2022 | clinicaltrials |
| NCT04831827 | Promoting Equity for Cancer Screening and Follow-up | withdrawn | N/A | 0 | Mayo ClinicOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT00900120 | Collecting and Storing Blood Samples From Patients With Cancer | withdrawn | — | 0 | University of Medicine and Dentistry of New JerseyOTHER | 0 | Sep 21, 2021 | clinicaltrials |
| NCT03068832 | Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | May 25, 2021 | clinicaltrials |
| NCT03107325 | Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging | withdrawn | Phase 4 | 0 | Boston Children's HospitalOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT03556930 | Simulated Radiotherapy Treatment Assisted With Pediatric Radiation Oncology With Movie Induced Sedation Effect Technique | withdrawn | Early Phase 1 | 0 | University of Texas Southwestern Medical CenterOTHER | 0 | Aug 27, 2020 | clinicaltrials |
| NCT04044378 | Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma | withdrawn | Phase 1 / Phase 2 | 0 | Peking University People's HospitalOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT03127254 | Can Making Video Narratives Benefit Adolescents With Cancer | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Apr 9, 2020 | clinicaltrials |
| NCT03577600 | Compassionate Treatment in Children With Brain Tumors With the Cytotron® | withdrawn | N/A | 0 | Hospital Infantil de Mexico Federico GomezOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT02747537 | Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan | withdrawn | Phase 2 | 0 | Washington University School of MedicineOTHER | 0 | Sep 9, 2019 | clinicaltrials |
| NCT02587871 | Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | Nov 9, 2018 | clinicaltrials |
| NCT00296049 | Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT00900445 | Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia | withdrawn | — | 0 | Children's Oncology GroupNETWORK | 1 | Aug 7, 2018 | clinicaltrials |
| NCT01453465 | Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor | withdrawn | — | 0 | Children's Oncology GroupNETWORK | 1 | Aug 7, 2018 | clinicaltrials |
| NCT01642095 | Studying Biomarkers in Samples From Younger Patients With Kidney Cancer | withdrawn | — | 0 | Children's Oncology GroupNETWORK | 1 | Aug 7, 2018 | clinicaltrials |
| NCT02011126 | Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors | withdrawn | Phase 2 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 7, 2018 | clinicaltrials |
| NCT02564536 | Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | May 8, 2017 | clinicaltrials |
| NCT02791919 | Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | May 3, 2017 | clinicaltrials |
| NCT02194452 | Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors | withdrawn | N/A | 0 | Sue O'DorisioOTHER | 1 | Apr 28, 2017 | clinicaltrials |
| NCT00607802 | Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Jan 19, 2017 | clinicaltrials |
| NCT02130934 | Cardiac 3D MRI in Pediatric Cancer Patients | withdrawn | — | 0 | Majd MakhoulOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02000986 | Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors | withdrawn | N/A | 0 | Virginia Commonwealth UniversityOTHER | 0 | Nov 20, 2015 | clinicaltrials |
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT01861990 | Valproic Acid in Childhood Progressive Brain Tumors | withdrawn | Phase 1 | 0 | Medical University of South CarolinaOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT01795430 | Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT01828502 | Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer | withdrawn | Phase 2 | 0 | University of South FloridaOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT00458744 | Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment | withdrawn | Phase 1 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 8, 2014 | clinicaltrials |
| NCT01896440 | Heart Safety Study of Ondansetron in Children Receiving Chemotherapy | withdrawn | Phase 4 | 0 | University of OklahomaOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01697514 | A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma | withdrawn | Phase 1 | 0 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
Data updated 5 days agoSource updated Sep 23, 2026source: clinicaltrials